By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...